1. HBW Insight

FDA Warnings Slow, But Anti-Aging Claims Remain Class Action Targets

 
• By Ryan Nelson

The online universe is abuzz with complaints about 2016, with some ready to dub the year “worst ever.” It certainly was a rough one for anti-aging skin-care marketers, and while FDA’s warning letter activity has declined of late, consumer lawsuits continue to file challenging companies’ clock-reversing promises.

FDA warning letters to skin-care players may be scarcer in the new year, compared with 2016, but firms continue to be at risk of consumers taking claims enforcement into their own hands with false-advertising class actions.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal

More from Policy & Regulation